Clinical Trials Browser

Phase 1 × Recruiting × dapagliflozin × Clear all

NCT05521984 2025-12-08

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Phase 1 Recruiting

Other solid neoplasm

Pediatric Brain Tumor

NCT04887935 2025-10-01

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT05989347 2025-03-19

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism